Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05267535 |
|
Recruitment Status :
Active, not recruiting
First Posted : March 4, 2022
Last Update Posted : November 8, 2023
|
Sponsor:
Neurim Pharmaceuticals Ltd.
Collaborator:
Syneos Health
Information provided by (Responsible Party):
Neurim Pharmaceuticals Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2024 |
| Estimated Study Completion Date : | June 2025 |